Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranibizumab and Reduced Fluence PDT for AMD (RAP)
This study is currently recruiting participants.
Study NCT00527475. Last updated on September 9, 2007.
Information provided by Texas Retina Associates
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Macular Degeneration
Additional conditions recognized in this trial
Choroidal Neovascularization
More general conditions related to this trial
Choroid Diseases
Eye Diseases
Metaplasia
Neovascularization, Pathologic
Pathologic Processes
Retinal Degeneration
Retinal Diseases
Uveal Diseases
Interventions listed in this trial
ranibizumab
verteporfin
More general drug interventions related to this trial
Dermatologic Agents
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Texas Retina Associates
Novartis
Back to top of Main Content